Gain Therapeutics (GANX) PT Lowered to $16 at B.Riley
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Price: $1.81 -5.24%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on Gain Therapeutics (NASDAQ: GANX) to $16.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Revolution (RVMD) PT Raised to $260 at Oppenheimer
- Freedom Broker Downgrades CF Industries (CF) to Hold, 'Strong Half, Softer Base Ahead'
- Elastic NV. (ESTC) PT Raised to $80 at DA Davidson Ahead of Q1 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
